Guatemala is intensifying its measles vaccination campaign in urban centers and religious communities amid a growing outbreak that has already claimed the lives of four infants and infected nearly 5,000 people, according to the country’s Ministry of Public Health and Social Assistance (MSPAS). Health officials are deploying mobile clinics and partnering with faith-based organizations to reach populations with historically low immunization rates, particularly in densely populated areas of Guatemala City and surrounding departments where vaccine hesitancy and access barriers have contributed to the spread of the highly contagious virus.
The outbreak, which began in early 2024, has disproportionately affected children under five, with health authorities confirming that the majority of cases involve unvaccinated or under-vaccinated individuals. In response, MSPAS has accelerated its immunization schedule, now offering the first dose of the measles, mumps, and rubella (MMR) vaccine to infants as young as six months in high-risk zones—a shift from the standard recommendation of 12 months. This emergency measure aims to close immunity gaps quickly, especially in communities where religious or cultural beliefs have led to delayed or refused vaccinations.
Measles, caused by the Morbillivirus, is one of the most infectious diseases known to humans, capable of spreading through airborne transmission when an infected person breathes, coughs, or sneezes. The virus can linger in the air for up to two hours after an infected person leaves a room, making crowded urban settings and large gatherings—such as religious services—particularly high-risk environments. Symptoms typically include high fever, cough, runny nose, red and watery eyes, and a characteristic red rash that spreads from the face to the rest of the body. Complications can include pneumonia, encephalitis, and death, particularly in young children and those with weakened immune systems.
According to data verified by the Pan American Health Organization (PAHO), Guatemala has reported 4,794 confirmed measles cases since January 2024, with the highest concentration in the departments of Guatemala, Sacatepéquez, and Chimaltenango. The four infant fatalities, all under six months of age, occurred in communities where vaccination coverage had fallen below the 95% threshold needed to prevent community transmission. PAHO and the World Health Organization (WHO) emphasize that two doses of the MMR vaccine are approximately 97% effective at preventing measles, and maintaining high coverage is critical to avoiding outbreaks.
Faith Leaders and Health Workers Join Forces to Boost Vaccine Uptake
Recognizing that distrust in government health initiatives has hindered immunization efforts in some religious communities, Guatemalan health authorities have begun collaborating with priests, pastors, and indigenous spiritual leaders to disseminate accurate information about vaccine safety and efficacy. In several neighborhoods of Guatemala City, mobile vaccination units now operate outside churches, mosques, and temples after services, offering free MMR shots to children and adults who may have missed prior doses.
This strategy mirrors successful outreach models used during the COVID-19 pandemic, when faith-based partnerships helped increase vaccine acceptance in hard-to-reach populations across Latin America. Local health promoters, many of whom are trained community members, are also conducting door-to-door education campaigns to address myths about vaccines causing infertility or long-term harm—claims that have circulated widely on social media despite being debunked by multiple peer-reviewed studies.
Dr. María Fernanda Ávila, a pediatric infectious disease specialist at Guatemala City’s Roosevelt Hospital, explained that overcoming vaccine hesitancy requires more than just access—it demands trust. “We’re not just administering shots; we’re listening to concerns, engaging in dialogue, and working with respected community figures to ensure families understand that vaccines are safe, effective, and the best protection we have against a disease that can kill a child in days,” she said in a recent interview with Guatemalan public health officials.
Global Context: Measles Resurgence Threatens Progress Toward Elimination
Guatemala’s outbreak is part of a troubling global trend. In 2023, measles cases increased by 18% worldwide compared to the previous year, with over 9 million cases and 136,000 deaths reported—mostly in children under five—according to the WHO and the U.S. Centers for Disease Control and Prevention (CDC). The backsliding is attributed to disruptions in routine immunization during the pandemic, declining vaccine confidence, and uneven access to health services in low- and middle-income countries.
The Americas had been declared free of endemic measles transmission in 2016, but imported cases and pockets of low vaccination have led to recurrent outbreaks in countries including Brazil, Venezuela, and now Guatemala. PAHO warns that without urgent action to close immunization gaps, the region risks losing its elimination status, which would exit millions of children vulnerable to a preventable disease.
International health agencies have pledged technical and logistical support to Guatemala’s vaccination drive. UNICEF has delivered over 1.2 million doses of MMR vaccine to the country since the outbreak began, whereas the CDC has provided epidemiological assistance to help trace transmission chains and identify high-risk zones. These efforts are being coordinated through Guatemala’s National Immunization Program, which oversees vaccine procurement, distribution, and monitoring nationwide.
What Parents and Caregivers Should Know
Health officials urge parents to ensure their children receive both doses of the MMR vaccine: the first at 12 months of age (or six months in outbreak-affected areas) and the second between 15 and 18 months. Adults who are unsure of their vaccination status, especially those born after 1957 who may not have been exposed to the virus or vaccinated, are also encouraged to get immunized, particularly if they work in healthcare, education, or travel internationally.
The MMR vaccine has been in use for over 50 years and has an excellent safety record. Common side effects are mild and temporary, including soreness at the injection site, low-grade fever, or a mild rash. Severe allergic reactions are extremely rare, occurring in fewer than one in a million doses. Health authorities stress that the risks of measles far outweigh any potential side effects from the vaccine.
For the most up-to-date information on vaccination sites, outbreak updates, and public health advisories, residents are directed to the official website of Guatemala’s Ministry of Public Health and Social Assistance (www.mspas.gob.gt) and the Pan American Health Organization’s Guatemala office (paho.org/gut). These platforms provide real-time data on case counts, vaccine availability, and guidance for communities affected by the outbreak.
As vaccination teams continue their work in plazas, parishes, and neighborhoods across the country, the message from health leaders is clear: stopping this outbreak requires not only vaccines, but also vigilance, compassion, and a shared commitment to protecting the most vulnerable. With coordinated action and sustained public trust, Guatemala aims to halt transmission and restore its progress toward measles elimination.
Stay informed, share verified information from trusted health sources, and consult your local health center if you have questions about your family’s vaccination status. Together, we can prevent further illness and save lives.